Patents by Inventor Melanie Stang

Melanie Stang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8822468
    Abstract: The invention relates to compounds of formula (I) and salts thereof wherein the substituents are as defined in the specification, the application of a compound of formula (I) in a process for the treatment of the human or animal body, in particular with regard to C-Met tyrosine kinase mediated disease; the use of a compound of formula (I) for manufacturing a medicament for the treatment of such diseases; pharmaceutical compositions comprising a compound of the formula (I), optionally in the presence of a combination partner; processes for the preparation of a compound of formula (I).
    Type: Grant
    Filed: March 2, 2009
    Date of Patent: September 2, 2014
    Assignee: Novartis AG
    Inventors: Pascal Furet, Clive McCarthy, Joseph Schoepfer, Carsten Spanka, Melanie Stang, Frederic Stauffer
  • Publication number: 20090264406
    Abstract: The invention relates to compounds of formula (I) and salts thereof wherein the substituents are as defined in the specification, the application of a compound of formula (I) in a process for the treatment of the human or animal body, in particular with regard to C-Met tyrosine kinase mediated disease; the use of a compound of formula (I) for manufacturing a medicament for the treatment of such diseases; pharmaceutical compositions comprising a compound of the formula (I), optionally in the presence of a combination partner; processes for the preparation of a compound of formula (I).
    Type: Application
    Filed: March 2, 2009
    Publication date: October 22, 2009
    Inventors: Pascal Furet, Clive McCarthy, Joseph Schoepfer, Carsten Spanka, Melanie Stang, Frederic Stauffer
  • Patent number: 7459581
    Abstract: Ester compounds of the formula I-a wherein R1 is selected from OH, NH2 and NH3+X?, wherein X is an inorganic anion, wherein R2 is a singly-branched saturated or unsaturated aliphatic hydrocarbon moiety selected from C7-C15, wherein R5 is selected from H, and a linear saturated or unsaturated aliphatic hydrocarbon moiety selected from C6-C14, and wherein R2 and R5 together have a total of 7 to 15 carbon atoms; that are useful as antibacterial or antifungal compounds in consumer products.
    Type: Grant
    Filed: August 31, 2005
    Date of Patent: December 2, 2008
    Assignee: Givaudan S.A.
    Inventors: Samuel Derrer, Andreas Natsch, Bernd Traupe, Melanie Stang
  • Publication number: 20080070985
    Abstract: Ester compounds of the formula I-a wherein R1 is selected from OH, NH2 and NH3+X?, wherein X is an inorganic anion, wherein R2 is a singly-branched saturated or unsaturated aliphatic hydrocarbon moiety selected from C7-C15, wherein R5 is selected from H, and a linear saturated or unsaturated aliphatic hydrocarbon moiety selected from C6-C14, and wherein R2 and R5 together have a total of 7 to 15 carbon atoms; that are useful as antibacterial or antifungal compounds in consumer products.
    Type: Application
    Filed: August 31, 2005
    Publication date: March 20, 2008
    Inventors: Samuel Derrer, Andreas Natsch, Bernd Traupe, Melanie Stang
  • Publication number: 20070276045
    Abstract: Acid compounds of formula I wherein Y is selected from O and NH, wherein X is selected from CO and CH2, and wherein R2 is a branched saturated or unsaturated hydrocarbon moiety selected from C7-C15, that are useful as antibacterial or antifungal compounds in consumer products.
    Type: Application
    Filed: August 26, 2005
    Publication date: November 29, 2007
    Inventors: Samuel Derrer, Andreas Natsch, Bernd Traupe, Melanie Stang